Doctors look back: how did a new asthma drug perform in real patients?
NCT ID NCT07013760
Summary
This study looked back at the medical records of 420 patients in Spain who received the asthma medication tezepelumab after it became available to the public. The goal was to understand the real-world characteristics of these patients and see how the treatment affected their asthma control, symptoms, and quality of life in routine care, not a controlled trial. Researchers collected data on patient backgrounds, asthma attacks, and various health questionnaires to assess the drug's impact.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Andalucia, Spain
-
Research Site
C. Valenciana, Spain
-
Research Site
C. Y Leon, Spain
-
Research Site
Cantabria, Spain
-
Research Site
Castilla La Mancha, Spain
-
Research Site
Cataluna, Spain
-
Research Site
Extremadura, Spain
-
Research Site
Galicia, Spain
-
Research Site
Islas Canarias, Spain
-
Research Site
Madrid, Spain
-
Research Site
Navarra, Spain
-
Research Site
Pais Vasco, Spain
Conditions
Explore the condition pages connected to this study.